In last month’s Russian feature, we investigated what looked to be a stunted and troubled market. Just as private healthcare was getting its act together the faltering economy has depleted disposable incomes and driven supply costs sky-high. Of course, the reality is more complex and conceals a number of opportunities. Ekaterina Timofeeva, for one, is optimistic. Margins of 40% or more are gone for now, but don’t give up on Russia just yet. She points to a new international medical cluster outside Moscow that is expected to attract 80bn roubles (€900m) of investment.